Israeli company BrainStorm Cell Therapeutics Inc. announced that it was awarded a NIS3 million (approx. $795,000) grant from Israel’s Office of the Chief Scientist (OCS) for the year 2013. The grant is intended to support BrainStorm’s Research and Development program for its innovative stem cell therapy candidate NurOwn.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments